BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10985216)

  • 1. Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
    Robins JM; Finkelstein DM
    Biometrics; 2000 Sep; 56(3):779-88. PubMed ID: 10985216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.
    Freedberg KA; Hardy WD; Holzman RS; Tosteson AN; Craven DE
    Med Decis Making; 1996; 16(1):29-35. PubMed ID: 8717596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
    Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
    Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
    Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
    Wilkinson SB
    Am J Med; 1995 Apr; 98(4):422-3. PubMed ID: 7709963
    [No Abstract]   [Full Text] [Related]  

  • 9. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial.
    Jensen BN; Nielsen TL; Backer V; Nelsing S; Simonsen L; Flaschs H; Gaub J; Højlyng N; Nielsen JO; Mathiesen L
    J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):472-7. PubMed ID: 8097788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
    Salmon-Ceron D; Fontbonne A; Saba J; May T; Raffi F; Chidiac C; Patey O; Aboulker JP; Schwartz D; Vildé JL
    J Infect Dis; 1995 Sep; 172(3):656-64. PubMed ID: 7658056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
    Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
    J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
    Lidman C; Berglund O; Tynell E; Lindbäck S; Elvin K
    AIDS; 1994 Jul; 8(7):935-9. PubMed ID: 7946102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.
    Golden JA; Katz MH; Chernoff DN; Duncan SM; Conte JE
    Chest; 1993 Sep; 104(3):743-50. PubMed ID: 8365284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
    Carr A; Tindall B; Penny R; Cooper DA
    AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of aerosol pentamidine prophylaxis.
    Ong EL
    Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS; Wara DW; Duliege AM
    J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.